PASSENGER LYMPHOCYTE SYNDROME

This adverse event was reported 61 times

PASSENGER LYMPHOCYTE SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BASILIXIMAB 20 0.0017
1 MYCOPHENILIC ACID 11 0.0005
2 TACROLIMUS OINTMENT 0.1% 44 0.0003
3 TACROLIMUS EXTENDED-RELEASE CAPSULES 44 0.0003
4 MYCOPHENOLIC ACID 11 0.0003
5 TACROLIMUS 46 0.0003
6 MYCOPHENOLATE MOFETIL 36 0.0003
7 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 36 0.0003
8 BUSULFAN 4 0.0003
9 CEFOTAXIME INJECTION 1 0.0002
See all drugs enriched for association with PASSENGER LYMPHOCYTE SYNDROME

PASSENGER LYMPHOCYTE SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Antimetabolite Immunosuppressant [EPC] 11 0.0005
1 Calcineurin Inhibitor Immunosuppressant [EPC] 14 0.0001
2 Antimalarial [EPC] 1 0.0001
3 Antiprotozoal [EPC] 1 0.0001
4 Human Immunoglobulin G [EPC] 1 0.0000
5 CD20-directed Cytolytic Antibody [EPC] 14 0.0000
6 Corticosteroid [EPC] 41 0.0000
7 Penem Antibacterial [EPC] 1 0.0000
8 Polyene Antifungal [EPC] 1 0.0000
9 Alkylating Drug [EPC] 5 0.0000
See all drug classes enriched for association with PASSENGER LYMPHOCYTE SYNDROME